Domicile
Groupes
Pages
Marketplace
Plus
Groupes Pages Marketplace Evènements Blogs Financement Offres Courses
Se connecter S’enregistrer
Mode nuit
Multiple Sclerosis Drugs Market to Reach USD 39.7 Billion by 2036, Driven by Rising MS Prevalence and Growing Adoption of High-Efficacy Disease-Modifying Therapies
Multiple Sclerosis Drugs Market Overview Multiple sclerosis (MS) drugs are therapeutic agents used to manage multiple sclerosis, a chronic autoimmune disease that affects the central nervous system. These therapies include disease-modifying treatments (DMTs), biologics, oral medications, and injectable therapies designed to reduce relapse rates, slow disease progression, and improve patient...
0 Commentaires ·0 Parts ·18 Vue ·0 Aperçu
Connectez-vous pour aimer, partager et commenter!